The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications
Conclusions
COVID-19 vaccination reduced the risk of post-COVID-19 cardiac and thromboembolic outcomes. These effects were more pronounced for acute COVID-19 outcomes, consistent with known reductions in disease severity following breakthrough versus unvaccinated SARS-CoV-2 infection.
Source: Heart - Category: Cardiology Authors: Mercade-Besora, N., Li, X., Kolde, R., Trinh, N. T., Sanchez-Santos, M. T., Man, W. Y., Roel, E., Reyes, C., Delmestri, A., Nordeng, H. M. E., Uusküla, A., Duarte-Salles, T., Prats, C., Prieto-Alhambra, D., Jödicke, A. M., Catala, M. Tags: Open access, Editor's choice, Press releases, COVID-19 Cardiac risk factors and prevention Source Type: research
More News: Cardiology | Cardiovascular | Covid Vaccine | COVID-19 | Databases & Libraries | Electronic Health Records (EHR) | Estonia Health | Heart | Heart Failure | SARS | Spain Health | Study | Thrombosis | Vaccines